The ORPHAN Cures Act (HR 946), a bipartisan bill that removes barriers to treating and curing rare diseases, was reintroduced ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and ...
The integration of AI in healthcare as a means by which to enhance diagnostic accuracy and treatment planning also appeared ...
Minds + Assembly, a 2024 MM+M Agency 100 honoree, added Chuck Hemann as chief integration officer and Jonathan Woodring as ...
Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5BOCA RATON, ...
Roche Pharma India appoints Rajwinder as new country general manager to propel growth and innovation
Roche Pharma India appoints Rajwinder as new country general manager to propel growth and innovation: Our Bureau, Bengaluru Thursday, January 30, 2025, 14:40 Hrs [IST] Roche Pharm ...
1d
Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON, Fla, Feb. 12, 2025 (GLOBE NEWSWIRE) -- INmune Bio ...
We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Bio-Rad Laboratories, Inc. (NYSE:BIO) stands against ...
Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary ... with Nippon Shinyaku Co. Ltd., a leading Japanese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback